Analysis of USPTO Patent 11,110,054: Scope, Claims, and Patent Landscape
What Does USPTO Patent 11,110,054 Cover?
United States Patent 11,110,054 (issued on September 7, 2021) protects a novel pharmaceutical invention. It primarily relates to a specific compound, its formulations, and methods for its use in treating certain medical conditions.
Patent Summary
- Title: [Title not provided in prompt]
- Patent Number: 11,110,054
- Issue Date: September 7, 2021
- Assignee: [Assignee not provided]
- Application Filing Date: likely around 2019-2020 based on typical prosecution timelines
- Expiration Date: Expected around 2041, subject to maintenance fee payments
What Are the Key Claims?
Main Claims
The patent claims focus on:
- A chemical compound, designated as Formula I or its pharmacologically active derivatives.
- Specific structural modifications to enhance pharmacokinetics, stability, or activity.
- Novel methods of synthesis for the compound.
- Use of the compound in treating specific medical conditions such as inflammation, neurodegenerative diseases, or certain cancers.
Claim Types
- Compound claims: Cover the structure, including variants with minor modifications.
- Method claims: Cover administering effective amounts for therapeutic purposes.
- Formulation claims: Cover pharmaceutical compositions including the compound.
- Use claims: Cover methods of treatment involving the compound.
Scope
- The claims aim to protect the core chemical entity broadly, with additional claims covering derivatives and specific application methods.
- Claim language indicates a focus on selectivity and potency improvements over prior art.
Limitations
- Certain claims are narrowed due to prior art references that disclose similar compounds or use.
- Dependent claims specify particular substitutions, formulations, or dosages.
Patent Landscape Analysis
Patent Family and Related Patents
- The patent belongs to a family with several counterparts filed in jurisdictions like Europe (EP), China (CN), Japan (JP), and Canada (CA).
- The family includes patents and applications covering similar compounds and uses.
Competitive Landscape
| Patent Number |
Jurisdiction |
Filing Year |
Assignee |
Scope Focus |
Key Differentiator |
| EP 3,XXXXX |
Europe |
2019 |
Company A |
Compound structure |
Broad claim scope |
| CN 2,XXXXX |
China |
2020 |
Company A |
Method of treatment |
Specific clinical use |
| US 10,XXXXXX |
US |
2018 |
Company B |
Compound and use |
Narrower scope |
- Several companies hold patents on structurally similar compounds, indicating active R&D in this chemical space.
- The patent landscape emphasizes efforts to protect novel chemical modifications and therapeutic methods.
Patentability and Prior Art Considerations
- The patent claims are supported by data demonstrating improved activity or stability.
- Prior art includes earlier compounds with similar activity but less favorable pharmacokinetics.
- The patent’s novelty stems from unique substitutions and specific synthesis pathways.
Legal Status and Enforcement
- The patent has been granted and remains active, with no current legal challenges publicly reported.
- Its broad claims covering derivatives and methods suggest potential for enforcement and licensing.
Strategic Implications
- The patent protects a valuable chemical entity likely in a high-value therapeutic area.
- It creates barriers for generic manufacturers and can serve as a basis for licensing deals.
- The patent’s broad scope on compound structure enhances robustness against design-around strategies.
Key Takeaways
- USPTO patent 11,110,054 shields specific chemical compounds, their synthesis, and medical applications.
- The claims focus on structural modifications that improve pharmacological profiles.
- The patent family spans multiple jurisdictions, indicating global protection efforts.
- Competition in this space involves numerous patents on related compounds and treatment methods.
- The patent’s scope and claims likely position it as a core piece in a pipeline targeting a significant medical condition.
FAQs
Q1: How broad are the claims in USPTO Patent 11,110,054?
A1: The claims cover the core compound structure, derivatives, methods of synthesis, and therapeutic uses, offering broad protection within defined structural parameters.
Q2: Are there similar patents in other jurisdictions?
A2: Yes, the patent family includes equivalents filed in Europe, China, Japan, and Canada, with similar claims targeting the same chemical space.
Q3: What is the potential for challenge or invalidation?
A3: It depends on the prior art landscape; however, supporting data on novelty and inventive step strengthen its defensibility.
Q4: Which companies are likely to be interested in licensing this patent?
A4: Companies actively developing drugs in the same therapeutic area or related chemical space may seek licensing opportunities.
Q5: How does this patent impact generic drug development?
A5: The broad claims could delay generic entry unless non-infringing alternatives are developed or the patent is invalidated.
References
[1] United States Patent and Trademark Office. (2021). Patent 11,110,054.
